首页> 外文期刊>Zeitschrift fur Gastroenterologie >Efficacy and complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors and exploration for influencing factors
【24h】

Efficacy and complications of submucosal tunneling endoscopic resection for upper gastrointestinal submucosal tumors and exploration for influencing factors

机译:粘膜下颌骨颌面透镜切除疗效和对影响因素的探索的疗效和并发症

获取原文
获取原文并翻译 | 示例
       

摘要

Background Submucosal tunneling endoscopic resection (STER) has emerged as a feasible technique for resecting upper gastrointestinal (GI) tract submucosal tumors (SMTs) through natural orifice transluminal endoscopic surgery. STER reduces the risk of postoperative perforation and abdominal infections and promotes rapid wound healing. The aim of this meta-analysis was to evaluate the safety and efficacy of STER for small (≤ 3.5 cm) upper GI SMTs and explore the potential factors influencing STER’s efficacy and complication rate. Methods Comprehensive literature searches were performed to find studies on STER for removal of SMTs. Several English-language databases were searched, including MEDLINE (through PubMed), EMBASE, and the Cochrane Library for the period January 2010 to June 2016. The medical terms “submucosal tunneling endoscopic resection or STER”, “upper gastrointestinal”, and “submucosal tumors” were used in the search. The primary outcome measures were the pooled estimates of the complete resection and en bloc resection rates. The secondary outcome measure was the pooled estimate of complications. Result Twelve studies including 397 patients and 430 lesions were identified. The pooled estimate of the complete resection rate was 98.1 % (95 % confidence interval [CI]: 95.9 – 99.2 %). The pooled estimate of en bloc resection was 94.9 % (95 % CI: 91.1 – 97.1 %). The pooled estimate of gas-related complications such as pneumoperitoneum and subcutaneous emphysema was 21.5 % (95 % CI: 13.2 – 33.1 %). The pooled estimate of inflammation-related complications including pleural and abdominal effusion was 8.4 % (95 % CI: 5.6 – 12.3 %). Gas-related complications occurred more frequently in the esophagogastric junction than in the stomach. In addition, the pooled estimate of delayed bleeding was 2.2 % (95 % CI: 1.0 – 4.7 %). Conclusion STER appeared to be an extremely effective technique for removing upper GI SMTs originating from the muscularis propria layer. In addition, the very low rate of complications also shows the safety of this technique. Tumor size, infiltration depth, and location may influence the complication rates.
机译:背景技术粘膜隧穿内窥镜切除(STER)作为通过天然孔口分流内窥镜手术切击上胃肠道(GI)缺陷肿瘤(SMT)的可行技术。分类率降低了术后穿孔和腹部感染的风险,促进了快速伤口愈合。该荟萃分析的目的是评估stent的小(≤3.5cm)的上GI SMTS的安全性和功效,并探索影响塞斯特氏术疗效和并发症率的潜在因素。方法进行全面的文学搜索,以查找对STER的研究以去除SMT。搜索了几个英语语言数据库,包括2010年1月至2016年6月期间的Medline(通过Pubmed),Embase和Cochrane图书馆。医学术语“粘膜隧穿内窥镜切除或锡氏”,“上胃肠”和“粘膜下粘膜肿瘤“被用于搜索。主要结果措施是完全切除和en Bloc切除率的汇总估计。二次结果措施是并发症的汇总估计。结果12项研究包括397名患者和430例病变。完全切除率的汇总估计为98.1%(95%置信区间[CI]:95.9 - 99.2%)。 Zhoc切除术的汇总估计为94.9%(95%CI:91.1-97.1%)。气体相关并发症等汇总估计,如气腹和皮下肺气肿为21.5%(95%CI:13.2-33.1%)。包含胸膜和腹部积液的炎症相关并发症的汇总估计为8.4%(95%CI:5.6-12.3%)。与胃中的食管胃部接线相比,气体相关的并发症发生了相关的并发症。此外,延迟出血的汇总估计为2.2%(95%CI:1.0-4.7%)。结论STER似乎是一种极其有效的技术,用于去除源自肌肉桥层的上GI SMT。此外,对该技术的安全性非常低。肿瘤大小,渗透深度和位置可能影响并发症率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号